Thirty-six progressive mCRPC patients received TLX591-Tx across three cohorts (enzalutamide, abiraterone, or docetaxel sequence), and all completed two planned doses without emergent, unexpected ...

Clinically known as benign prostatic hyperplasia (BPH), enlarged prostate is a non‑cancerous condition that affects roughly half of men ages 51 to 60, with incidence increasing ...

Researchers have found in a new study that among men with prostate cancer undergoing androgen deprivation therapy, use of oxybutynin 5 mg twice daily significantly reduced the frequency ...

In today's time, prostate has become a serious problem in men, which can be identified by some symptoms and can be treated in ...

Researchers found men who ejaculated more often had fewer prostate cancer diagnoses, pointing to a possible biological ...

Doctors share healthful habits for managing urination and debunk misconceptions about trips to the bathroom ...

An experimental immunotherapy drug called VIR-5500 has driven prostate-specific antigen (PSA) levels down by as much as 99% in some men with metastatic castration-resistant prostate cancer, according ...

Prostate cancer is the most common cancer in men throughout the United States. Most men do not realize they have cancer due ...

Oxybutynin significantly reduced hot flash frequency and severity compared with placebo among men with prostate cancer ...

Prostate Cancer UK is urging for sanitary bins to be added in men's public toilets. The charity contends that men ...

I am in relatively good health for an 82-year-old male. For the past six years, I have been having trouble with an overactive ...

Dear Dr. Roach: My son, age 52, had recent lab results showing that his Lipoprotein (a) level was elevated, at 172 nmol/L. He is in very good health after a recent ablation for atrial fibrillation. We ...